Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 373 entries
View as:

Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants

Phase: N/A Priority: Normal
NCT ID: NCT06800885 Org: User:
Start: 10/22/24 End: 05/31/26 Due: 05/31/27

A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

Phase: N/A Priority: Normal
NCT ID: NCT03958799 Org: User:
Start: 06/26/19 End: 04/06/21 Due: 04/06/22

Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2

Phase: N/A Priority: Normal
NCT ID: NCT04222985 Org: User:
Start: 02/18/20 End: 05/19/21 Due: 05/19/22

Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00777257 Org: User:
Start: 04/30/05 End: 09/30/07 Due: 09/30/08

Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA

Phase: N/A Priority: Normal
NCT ID: NCT02012998 Org: User:
Start: 01/31/14 End: 02/28/15 Due: 02/28/16

Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV

Phase: N/A Priority: Normal
NCT ID: NCT01190228 Org: User:
Start: 08/25/10 End: 10/12/15 Due: 10/12/16

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01946425 Org: User:
Start: 09/30/13 End: 07/31/14 Due: 07/31/15

Safety and Immune Response of Different Pediatric Combination Vaccines.

Phase: N/A Priority: Normal
NCT ID: NCT00255047 Org: User:
Start: 11/30/05 End: 02/28/09 Due: 02/28/10

Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years

Phase: N/A Priority: Normal
NCT ID: NCT01712984 Org: User:
Start: 10/31/12 End: 10/31/13 Due: 10/31/14

Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Phase: N/A Priority: Normal
NCT ID: NCT04825223 Org: User:
Start: 03/29/21 End: 07/22/22 Due: 07/22/23

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

Phase: N/A Priority: Normal
NCT ID: NCT01887912 Org: User:
Start: 07/30/13 End: 06/12/18 Due: 06/12/19

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

Phase: N/A Priority: Normal
NCT ID: NCT01491087 Org: User:
Start: 12/31/11 End: 12/31/12 Due: 12/31/13

Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia

Phase: N/A Priority: Normal
NCT ID: NCT00444951 Org: User:
Start: 02/28/07 End: 02/28/09 Due: 02/28/10

A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

Phase: N/A Priority: Normal
NCT ID: NCT00952419 Org: User:
Start: 08/31/09 End: 06/30/10 Due: 06/30/11

Zika Case Definition and Surveillance Study

Phase: N/A Priority: Normal
NCT ID: NCT03158233 Org: User:
Start: 04/29/17 End: 12/19/18 Due: 12/19/19

Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT00343421 Org: User:
Start: 07/31/06 End: 06/30/09 Due: 06/30/10

Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT04969276 Org: User:
Start: 07/16/21 End: 02/08/22 Due: 02/08/23

Immunogenicity and Safety of a Purified Vero Rabies Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03145766 Org: User:
Start: 04/17/17 End: 01/08/18 Due: 01/08/19

Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™

Phase: N/A Priority: Normal
NCT ID: NCT00654901 Org: User:
Start: 03/31/08 End: 07/31/09 Due: 07/31/10

Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®

Phase: N/A Priority: Normal
NCT ID: NCT00836953 Org: User:
Start: 09/30/03 End: 07/31/04 Due: 07/31/05

Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

Phase: N/A Priority: Normal
NCT ID: NCT00621764 Org: User:
Start: 03/31/08 End: 05/31/13 Due: 05/31/14

Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT02699840 Org: User:
Start: 02/29/16 End: 07/25/16 Due: 07/25/17

Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

Phase: N/A Priority: Normal
NCT ID: NCT03541694 Org: User:
Start: 04/11/18 End: 05/30/18 Due: 05/30/19

A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01049035 Org: User:
Start: 12/16/09 End: 02/13/12 Due: 02/13/13

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02199691 Org: User:
Start: 07/22/14 End: 10/02/15 Due: 10/02/16